A. Castro

发表

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

C. Pérez, Ana Martínez, M. Alonso, 2002, Journal of medicinal chemistry.

Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?

Ana Martínez, A. Castro, I. Dorronsoro, 2002 .

Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease.

Ana Martínez, S. Wahyuono, M. Hamann, 2007, Journal of natural products.

The use of molecular similarity indices in the determination of a bioactive conformation

W. Richards, A. Castro, 1998 .

Kinase activators as a novel class of antidiabetic agents

A. Castro, 2012 .

Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors

M. Medina, A. Castro, Ana Martinez, 2006 .

Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors

Ana Martínez, C. Gil, M. J. Jerez, 2005, Medicinal research reviews.

BASE PROMOTED TRANSFORMATION ON THIADIAZOLOPYRIDINIUM CHLORIDES

Ana Martínez, A. Castro, J. Fayet, 1997 .

An Experimental NMR and Semi-Empirical Theoretical Study of the Conformation of Styrylchromones and Styryl Alkyl or Aryl Ketones (Benzylidene Ketones) †

J. Elguero, J. Cavaleiro, Artur M. S. Silva, 2002 .

Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.

A. Castro, A. Martínez, 2001, Mini reviews in medicinal chemistry.

Tautomerism of benzo- and cyclopenta-[1,2,6]thiadiazine S,S-dioxides

Ana Martínez, A. Castro, 1994 .

Non-cholinergic pharmacotherapy approaches to the future treatment of Alzheimer's disease.

Ana Martínez, S. Conde, M. Rodríguez-Franco, 2002, Mini reviews in medicinal chemistry.

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease

Ana Martínez, A. Castro, 2006, Expert opinion on investigational drugs.

Novel agents for the treatment of human cytomegalovirus infection

Ana Martínez, A. Castro, 2000 .

Regioselective Lipase‐Catalysed Amidation of Dicarboxylic N‐Blocked Amino Acid Diesters – Effect of the Side‐Chain Length

Ana Martínez, S. Conde, A. Castro, 1999 .

Synthesis and nematocide activity of S-glycopyranosyl-6,7-diarylthiolumazines.

N. Campillo, N. D'Accorso, M. M. Martins Alho, 2004, Bioorganic & medicinal chemistry.

Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

Ana Martínez, M. Alonso, A. Castro, 2002, Medicinal research reviews.

Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors.

Ana Martínez, A. Castro, 2006, Current pharmaceutical design.

Marine compounds for the therapeutic treatment of neurological disorders

Ana Martínez, A. Castro, Diana Alonso, 2005 .

The Tautomerism of 5-Amino-3-oxo-1,2,4-thiadiazole: An Experimental and Theoretical Study

N. Campillo, J. A. Páez, A. Castro, 2007 .

Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders

Ana Martínez, A. Castro, 2000 .

Studies on the reactivity of some N-aryl- and N-heteroaryl-N'-alkylthioureas towards electrophilic reagents. Synthesis of new N-pyridylthioureas and thiazolines maría

A. Castro, I. Dorronsoro, I. Rodriguez-Franco, 2001 .

New Synthetic Route to of 1,2,4-Thiadiazolines and 1,3-Thiazolines via Thiadiazolopyridinium Salts

Ana Martínez, F. H. Cano, M. Martínez-Ripoll, 1996 .

Synthesis of nonsymmetrically 3,4-disubstituted 1,2,5-thiadiazole dioxides

V. Arán, J. Palacios, Ana Martínez, 1998 .

Understanding the Mechanism of Direct Activation of AMP-Kinase: Toward a Fine Allosteric Tuning of the Kinase Activity

F. J. Luque, Elnaz Aledavood, Gleiciane Moraes, 2019, J. Chem. Inf. Model..

Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic.

M. Medina, A. Castro, 2008, Current opinion in drug discovery & development.

Peripheral and dual binding site inhibitors of acetylcholinesterase as neurodegenerative disease modifying agents

Ana Martínez, A. Castro, I. Dorronsoro, 2003 .

Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

Mercedes Alonso, Ana Martínez, M. Alonso, 2002, Medicinal research reviews.

Gene therapy for cystic fibrosis

A. Castro, A. Boyd, Ana Martínez, 2001 .

Comparative Molecular Field Analysis (CoMFA) on [6] + [6] Fused Pyrazines with Nematocide Properties

Ana Martínez, C. Ochoa, A. Castro, 1997 .

Bioactive prenylated phenyl derivatives derived from marine natural products: novel scaffolds for the design of BACE inhibitors

J. Sánchez-Quesada, M. Medina, A. Castro, 2014 .